P052 Case series: a rare form of calcinosis in patients with systemic sclerosis-myositis overlap
Abstract Background/Aims Calcinosis is a well described entity that occurs in systemic sclerosis (SSc) and dermatomyositis. In patients with SSc, calcinosis typically occurs over pressure points but very rarely, widespread calcinosis may occur, presenting in an extensive pattern. We present a case s...
Gespeichert in:
Veröffentlicht in: | Rheumatology (Oxford, England) England), 2022-04, Vol.61 (Supplement_1) |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Background/Aims
Calcinosis is a well described entity that occurs in systemic sclerosis (SSc) and dermatomyositis. In patients with SSc, calcinosis typically occurs over pressure points but very rarely, widespread calcinosis may occur, presenting in an extensive pattern. We present a case series of four patients with SSc with this rarer form of diffuse calcinosis with the aim of raising awareness of this poorly recognised pattern of debilitating disease.
Methods
Four cases of SSc with extensive calcinosis were identified from a cohort of 461 patients with SSc who had attended a tertiary referral centre over the preceding 3 years, and their case notes reviewed.
Results
Demographic and clinical features of the four patients are summarised in Table 1. All four patients had the diffuse cutaneous subtype of SSc in the context of 102 patients [22%] of the entire SSc cohort of 461 patients, and all had overlapping features of myositis. Two were anti-Scl 70 antibody positive and the other two were anti-PMScl- positive. Widespread calcinosis was evident in all four patients in a pattern akin to ‘sheets’ of calcified deposits, very different to the lobular pattern of disease that has been well-described in the literature. Development of calcinosis occurred between one and six years of the onset of SSc, and in one patient the calcinosis discharged through skin at multiple sites. In all patients, treatment included mycophenolate mofetil. Treatments tried for the calcinosis included intravenous sodium thiosulfate in two patients (on the basis of anecdotal reports), but without significant clinical improvement.
P052 Table 1:
Demographic and clinical features.
Characteristic
Case 1
Case 2
Case 3
Case 4
Current age (years)
68
70
51
33
Age at diagnosis of systemic sclerosis (years)
65
65
42
27
Sex
Male
Female
Female
Female
Estimated disease duration prior to onset of calcinosis
1 year
3 years
6 years
2 years
Auto-antibody profile
Anti- Scl70 +ve
Anti-PMScl-75 weakly +ve, Anti- PMScl-100 weakly +ve
Anti-PMScl +ve
Anti- Scl70 +ve, dsDNA +ve
Imaging features
Calcinosis around the pelvis, upper femora, elbows, first web space of the hands (bilateral), distal rib cage
Calcinosis around the forearms, elbows, thighs and hands
Calcinosis around the pelvis
Calcinosis of upper arms, thighs, legs and left wrist
Previous or current treatments
Mycophenolate mofetil 1g BD, Prednisolone (maximum dose 20mg daily), Minocycline 50mg daily
Mycophenolate mofetil 1g BD, Prednisolone ( |
---|---|
ISSN: | 1462-0324 1462-0332 |
DOI: | 10.1093/rheumatology/keac133.051 |